Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Abnormal Locus Coeruleus Sleep Activity Alters Sleep Signatures of Memory Consolidation and Impairs Place Cell Stability and Spatial Memory.

Swift KM, Gross BA, Frazer MA, Bauer DS, Clark KJD, Vazey EM, Aston-Jones G, Li Y, Pickering AE, Sara SJ, Poe GR.

Curr Biol. 2018 Nov 19;28(22):3599-3609.e4. doi: 10.1016/j.cub.2018.09.054. Epub 2018 Nov 1.

PMID:
30393040
2.

Phasic locus coeruleus activity regulates cortical encoding of salience information.

Vazey EM, Moorman DE, Aston-Jones G.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9439-E9448. doi: 10.1073/pnas.1803716115. Epub 2018 Sep 19.

PMID:
30232259
3.

Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors.

Vazey EM, den Hartog CR, Moorman DE.

Handb Exp Pharmacol. 2018 Apr 24. doi: 10.1007/164_2018_108. [Epub ahead of print]

PMID:
29687164
4.

Noradrenergic Regulation of Central Amygdala in Aversive Pavlovian-to-Instrumental Transfer.

Campese VD, Soroeta JM, Vazey EM, Aston-Jones G, LeDoux JE, Sears RM.

eNeuro. 2017 Oct 24;4(5). pii: ENEURO.0224-17.2017. doi: 10.1523/ENEURO.0224-17.2017. eCollection 2017 Sep-Oct.

5.

Increased locus coeruleus tonic activity causes disengagement from a patch-foraging task.

Kane GA, Vazey EM, Wilson RC, Shenhav A, Daw ND, Aston-Jones G, Cohen JD.

Cogn Affect Behav Neurosci. 2017 Dec;17(6):1073-1083. doi: 10.3758/s13415-017-0531-y.

PMID:
28900892
6.

Stress Facilitates the Development of Cognitive Dysfunction After Chronic Ethanol Exposure.

Rodberg EM, den Hartog CR, Anderson RI, Becker HC, Moorman DE, Vazey EM.

Alcohol Clin Exp Res. 2017 Sep;41(9):1574-1583. doi: 10.1111/acer.13444. Epub 2017 Jul 28.

7.

New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.

Kelberman MA, Vazey EM.

Curr Pharmacol Rep. 2016 Dec;2(6):253-261. doi: 10.1007/s40495-016-0071-0. Epub 2016 Sep 28.

8.

Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.

Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm AC, Aston-Jones GS, Eckert MA.

Neuroimage. 2015 Jun;113:235-45. doi: 10.1016/j.neuroimage.2015.03.020. Epub 2015 Mar 17.

9.

Designer receptors enhance memory in a mouse model of Down syndrome.

Fortress AM, Hamlett ED, Vazey EM, Aston-Jones G, Cass WA, Boger HA, Granholm AC.

J Neurosci. 2015 Jan 28;35(4):1343-53. doi: 10.1523/JNEUROSCI.2658-14.2015.

10.

Designer receptors: therapeutic adjuncts to cell replacement therapy in Parkinson's disease.

Vazey EM, Aston-Jones G.

J Clin Invest. 2014 Jul;124(7):2858-60. doi: 10.1172/JCI76833. Epub 2014 Jun 17.

11.

Designer receptors show role for ventral pallidum input to ventral tegmental area in cocaine seeking.

Mahler SV, Vazey EM, Beckley JT, Keistler CR, McGlinchey EM, Kaufling J, Wilson SP, Deisseroth K, Woodward JJ, Aston-Jones G.

Nat Neurosci. 2014 Apr;17(4):577-85. doi: 10.1038/nn.3664. Epub 2014 Mar 2.

12.

Designer receptor manipulations reveal a role of the locus coeruleus noradrenergic system in isoflurane general anesthesia.

Vazey EM, Aston-Jones G.

Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3859-64. doi: 10.1073/pnas.1310025111. Epub 2014 Feb 24.

13.

New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's disease.

Vazey EM, Aston-Jones G.

Brain Res. 2013 May 20;1511:153-63. doi: 10.1016/j.brainres.2013.01.021. Epub 2013 Jan 18. Review.

14.

Stem cell-based therapy for Huntington's disease.

Maucksch C, Vazey EM, Gordon RJ, Connor B.

J Cell Biochem. 2013 Apr;114(4):754-63. doi: 10.1002/jcb.24432. Review.

PMID:
23097329
15.

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease.

Vazey EM, Aston-Jones G.

Front Behav Neurosci. 2012 Jul 25;6:48. doi: 10.3389/fnbeh.2012.00048. eCollection 2012.

16.

Use of vivo-morpholinos for control of protein expression in the adult rat brain.

Reissner KJ, Sartor GC, Vazey EM, Dunn TE, Aston-Jones G, Kalivas PW.

J Neurosci Methods. 2012 Jan 30;203(2):354-60. doi: 10.1016/j.jneumeth.2011.10.009. Epub 2011 Oct 17.

17.
18.

Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease.

Vazey EM, Dottori M, Jamshidi P, Tomas D, Pera MF, Horne M, Connor B.

Cell Transplant. 2010;19(8):1055-62. doi: 10.3727/096368910X494632. Epub 2010 Mar 26.

PMID:
20350346
19.

In vitro priming to direct neuronal fate in adult neural progenitor cells.

Vazey EM, Connor B.

Exp Neurol. 2009 Apr;216(2):520-4. doi: 10.1016/j.expneurol.2008.12.023. Epub 2009 Jan 7.

PMID:
19166836
20.

Temporal profile of subventricular zone progenitor cell migration following quinolinic acid-induced striatal cell loss.

Gordon RJ, Tattersfield AS, Vazey EM, Kells AP, McGregor AL, Hughes SM, Connor B.

Neuroscience. 2007 Jun 8;146(4):1704-18. Epub 2007 Apr 24.

PMID:
17459592

Supplemental Content

Loading ...
Support Center